ArticleInternational journal of pharmaceutics: X2023

Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug.

Xiaonan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.